Back to dashboard
CommercialCoverageMedium impact

08.01.97b, Spesolimab-sbzo (Spevigo®)

Independence Blue Cross·Dermatology, Rheumatology, Gastroenterology·Pharmacy
Effective date
May 28, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

The policy for Spesolimab-sbzo (Spevigo®) under code 08.01.97b has been reissued with updates to commercial insurance coverage. This appears to be a pharmacy policy update that will take effect May 28, 2025, though specific changes are not detailed in the summary provided.

Action Required

Action needed
Before May 28, 2025: Billing team should review the full policy document at the provided URL to understand specific changes to Spesolimab-sbzo (Spevigo®) coverage requirements. Update billing system and pharmacy billing procedures accordingly based on the detailed policy content.

Related policy hubs